Clinicopathological characteristics and recurrence risk of papillary thyroid microcarcinoma in the elderly

被引:16
作者
Wang, Xiaofei [1 ]
Lei, Jianyong [1 ]
Wei, Tao [1 ]
Zhu, Jingqiang [1 ]
Li, Zhihui [1 ]
机构
[1] Sichuan Univ, West China Hosp, Dept Thyroid & Parathyroid Surg, 37 GuoXueXiang, Chengdu, Sichuan, Peoples R China
关键词
papillary thyroid microcarcinoma; recurrence; elderly; LYMPH-NODE METASTASIS; REMNANT ABLATION; TUMOR SIZE; CANCER; CARCINOMA; OUTCOMES; PATIENT; GUIDELINES; MANAGEMENT; PROGNOSIS;
D O I
10.2147/CMAR.S198451
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Background: The optimal management for elderly patients with papillary thyroid microcarcinoma (PTMC) is not well established. The aim of the present study is to describe the clinicopathological characteristics and identify predictors of recurrence in the elderly PTMC patients. Methods: We conducted a retrospective study of PTMC patients who underwent thyroidectomy. The clinicopathological characteristics were compared between patients with age >= 65 years and <65 years. The independent predictors of recurrence were identified by multivariate Cox regression analysis. Results: The patients in elderly group were more likely to exhibit bilaterality (P<0.050), extrathyroidal extension (P<0.001), and central compartment lymph node metastasis (CLNM) (P<0.010), especially the ratio of CLNM >0.5 (P<0.010), than the patients with age <65 years. The elderly patients had poorer recurrence-free survival (RFS) than those with younger ages (P=0.002). Multivariate analysis indicated tumor size >5 mm (P=0.009) and CLNM ratio >0.5 (P=0.002) were independent risk factors for recurrence of the elderly patients with PTMC. Conclusions: The elderly PTMC patients have more aggressive biological characteristics and higher recurrence rate. More aggressive treatment and rigorous follow-up could be considered for elderly patients with tumor diameter >5 mm and CLNM ratio >0.5.
引用
收藏
页码:2371 / 2377
页数:7
相关论文
共 44 条
[1]  
Amin MB., 2016, AJCC Cancer Staging Manual, V8th
[2]   T1a Versus T1b Differentiated Thyroid Cancers: Do We Need to Make the Distinction? [J].
Anderson, Kevin L., Jr. ;
Youngwirth, Linda M. ;
Scheri, Randall P. ;
Stang, Michael T. ;
Roman, Sanziana A. ;
Sosa, Julie A. .
THYROID, 2016, 26 (08) :1046-1052
[3]  
[Anonymous], CANCER, DOI DOI 10.1002/1097-0142(19850801)56:3!
[4]   Approach to the Patient with Incidental Papillary Microcarcinoma [J].
Bernet, Victor .
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 2010, 95 (08) :3586-3592
[5]   Attributable costs of differentiated thyroid cancer in the elderly Medicare population DISCUSSION [J].
Tufano, Ralph P. ;
Boltz, Melissa M. ;
Lubitz, Carrie C. ;
Sturgeon, Cord ;
Sippel, Rebecca S. .
SURGERY, 2013, 154 (06) :1369-1370
[6]  
CADY B, 1988, SURGERY, V104, P947
[7]   Differentiated thyroid cancer in the elderly: Our experience [J].
Calo, Pietro Giorgio ;
Medas, Fabio ;
Loi, Giulia ;
Erdas, Enrico ;
Pisano, Giuseppe ;
Nicolosi, Angelo .
INTERNATIONAL JOURNAL OF SURGERY, 2014, 12 :S140-S143
[8]   Increasing Incidence of Differentiated Thyroid Cancer in the United States, 1988-2005 [J].
Chen, Amy Y. ;
Jemal, Ahmedin ;
Ward, Elizabeth M. .
CANCER, 2009, 115 (16) :3801-3807
[9]   Prognosis of papillary thyroid carcinoma in elderly patients after thyroid resection A retrospective cohort analysis [J].
Chereau, Nathalie ;
Tresallet, Christophe ;
Noullet, Severine ;
Godiris-Petit, Gaelle ;
Tissier, Frederique ;
Leenhardt, Laurence ;
Menegaux, Fabrice .
MEDICINE, 2016, 95 (47)
[10]   Current Thyroid Cancer Trends in the United States [J].
Davies, Louise ;
Welch, H. Gilbert .
JAMA OTOLARYNGOLOGY-HEAD & NECK SURGERY, 2014, 140 (04) :317-322